On Jun. 14, 2007, the U.D. of Health and Human Services (HHS) awarded $132.5 million to Sanofi Pasteur and MedImmune over five years to retrofit existing domestic vaccine manufacturing facilities on a cost-sharing basis and to provide warm-base operations for manufacturing pandemic influenza vaccines.

Sanofi reported it had been awarded $77.4 million to redesign a plant in Pennsylvania and the Health and Human Services Department said it had given $55 million to MedImmune to retrofit its facilities in several states.